New hope for lymphoma patients when other treatments fail
NCT ID NCT07195799
Summary
This study is testing whether adding a new drug called linperlisib to an existing three-drug combination helps control non-Hodgkin lymphoma that has come back or hasn't responded to previous treatments. It will involve about 180 adults with specific types of lymphoma to see if the four-drug combination is more effective and safe. The main goal is to measure how many patients' tumors shrink or disappear with this new approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital with Nanjing Medical University
RECRUITINGNanjing, Jiangsu, 210029, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.